These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


109 related items for PubMed ID: 12970632

  • 1. Lower concentration of pulmonary hepatocyte growth factor is associated with more severe lung disease in preterm infants.
    Lassus P, Heikkilä P, Andersson LC, von Boguslawski K, Andersson S.
    J Pediatr; 2003 Aug; 143(2):199-202. PubMed ID: 12970632
    [Abstract] [Full Text] [Related]

  • 2. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease.
    Hasan J, Beharry KD, Valencia AM, Strauss A, Modanlou HD.
    Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766
    [Abstract] [Full Text] [Related]

  • 3. Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia.
    Farhath S, He Z, Nakhla T, Saslow J, Soundar S, Camacho J, Stahl G, Shaffer S, Mehta DI, Aghai ZH.
    Pediatrics; 2008 Feb; 121(2):e253-9. PubMed ID: 18245400
    [Abstract] [Full Text] [Related]

  • 4. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops.
    Watterberg KL, Demers LM, Scott SM, Murphy S.
    Pediatrics; 1996 Feb; 97(2):210-5. PubMed ID: 8584379
    [Abstract] [Full Text] [Related]

  • 5. Pulmonary endostatin perinatally and in lung injury of the newborn infant.
    Janér J, Andersson S, Haglund C, Lassus P.
    Pediatrics; 2007 Jan; 119(1):e241-6. PubMed ID: 17158946
    [Abstract] [Full Text] [Related]

  • 6. Angiopoietin 2 concentrations in infants developing bronchopulmonary dysplasia: attenuation by dexamethasone.
    Aghai ZH, Faqiri S, Saslow JG, Nakhla T, Farhath S, Kumar A, Eydelman R, Strande L, Stahl G, Leone P, Bhandari V.
    J Perinatol; 2008 Feb; 28(2):149-55. PubMed ID: 18033304
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
    Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, Wrage LA, Poole K, National Institutes of Child Health and Human Development Neonatal Research Network.
    Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
    [Abstract] [Full Text] [Related]

  • 10. High concentrations of plasminogen activator inhibitor-1 in lungs of preterm infants with respiratory distress syndrome.
    Cederqvist K, Sirén V, Petäjä J, Vaheri A, Haglund C, Andersson S.
    Pediatrics; 2006 Apr; 117(4):1226-34. PubMed ID: 16585319
    [Abstract] [Full Text] [Related]

  • 11. Surfactant kinetics in preterm infants on mechanical ventilation who did and did not develop bronchopulmonary dysplasia.
    Cogo PE, Zimmermann LJ, Pesavento R, Sacchetto E, Burighel A, Rosso F, Badon T, Verlato G, Carnielli VP.
    Crit Care Med; 2003 May; 31(5):1532-8. PubMed ID: 12771629
    [Abstract] [Full Text] [Related]

  • 12. Vascular endothelial growth factor in human preterm lung.
    Lassus P, Ristimäki A, Ylikorkala O, Viinikka L, Andersson S.
    Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1429-33. PubMed ID: 10228106
    [Abstract] [Full Text] [Related]

  • 13. Matrix metalloproteinases-2, -8, and -9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress.
    Cederqvist K, Sorsa T, Tervahartiala T, Maisi P, Reunanen K, Lassus P, Andersson S.
    Pediatrics; 2001 Sep; 108(3):686-92. PubMed ID: 11533337
    [Abstract] [Full Text] [Related]

  • 14. Increased volume of tracheal aspirate fluid predicts the development of bronchopulmonary dysplasia.
    Iwatani S, Mizobuchi M, Tanaka S, Inomata K, Sakai H, Yoshimoto S, Nakao H.
    Early Hum Dev; 2013 Feb; 89(2):113-7. PubMed ID: 22980969
    [Abstract] [Full Text] [Related]

  • 15. PCO2 and room air saturation values in premature infants at risk for bronchopulmonary dysplasia.
    Kaempf JW, Campbell B, Brown A, Bowers K, Gallegos R, Goldsmith JP.
    J Perinatol; 2008 Jan; 28(1):48-54. PubMed ID: 18033306
    [Abstract] [Full Text] [Related]

  • 16. Effect of early ambroxol treatment on lung functions in mechanically ventilated preterm newborns who subsequently developed a bronchopulmonary dysplasia (BPD).
    Schmalisch G, Wauer RR, Böhme B.
    Respir Med; 2000 Apr; 94(4):378-84. PubMed ID: 10845438
    [Abstract] [Full Text] [Related]

  • 17. Increase in cord blood soluble E-selectin and tracheal aspirate neutrophils at birth and the development of new bronchopulmonary dysplasia.
    Kim BI, Lee HE, Choi CW, Jo HS, Choi EH, Koh YY, Choi JH.
    J Perinat Med; 2004 Apr; 32(3):282-7. PubMed ID: 15188806
    [Abstract] [Full Text] [Related]

  • 18. Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn.
    Lassus P, Turanlahti M, Heikkilä P, Andersson LC, Nupponen I, Sarnesto A, Andersson S.
    Am J Respir Crit Care Med; 2001 Nov 15; 164(10 Pt 1):1981-7. PubMed ID: 11734455
    [Abstract] [Full Text] [Related]

  • 19. Peptide growth factors in tracheal aspirates of mechanically ventilated preterm neonates.
    Ambalavanan N, Novak ZE.
    Pediatr Res; 2003 Feb 15; 53(2):240-4. PubMed ID: 12538781
    [Abstract] [Full Text] [Related]

  • 20. IFN-γ and IP-10 in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia.
    Aghai ZH, Saslow JG, Mody K, Eydelman R, Bhat V, Stahl G, Pyon K, Bhandari V.
    Pediatr Pulmonol; 2013 Jan 15; 48(1):8-13. PubMed ID: 22431160
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.